Perpustakaan Universitas Mahasaraswati

  • Beranda
  • Informasi
  • Berita
  • Bantuan
  • Pustakawan
  • Area Anggota
  • Pilih Bahasa :
    Bahasa Arab Bahasa Bengal Bahasa Brazil Portugis Bahasa Inggris Bahasa Spanyol Bahasa Jerman Bahasa Indonesia Bahasa Jepang Bahasa Melayu Bahasa Persia Bahasa Rusia Bahasa Thailand Bahasa Turki Bahasa Urdu
Image of FRONTIERS RESEARCH TOPICS : Phenotypic Screening in the 21st Century

Electronic Resource

FRONTIERS RESEARCH TOPICS : Phenotypic Screening in the 21st Century

Birgit T. Priest - Nama Orang; Gul Erdemli - Nama Orang;

Since the advent of molecular cloning, target based screening has become the norm in pharmaceutical drug discovery. A large number of potential drug targets have been cloned and functionally expressed, and enormous progress has been made in the development, miniaturization and automation of cell based assays on target molecules recombinantly expressed in mammalian cell lines. This approach has delivered many clinical candidates but relatively few new drugs. Target based screening is likely to provide very good drug candidates for monogenic diseases, and the following collection of manuscripts is not meant to discourage the use of target based approaches. However, most of the more prevalent human diseases are most likely multifactorial and require interaction with multiple targets to produce clinically meaningful efficacy. In addition, high potency, selective interaction with a single target may increases the risk of adverse events or be limited by redundancies and adaptive resistance. Here, target agnostic approaches using phenotypic assays may offer significant benefit. Making such approaches viable requires addressing a number of challenges. This e-book attempts to discuss some of these challenges and illustrate recent advances. Prior to the 1980s, most drugs were discovered using phenotypic assays in live animals or isolated tissues (Swinney, 2013). Most of these drugs interact relatively weakly with a number of targets, and the complete profile of their molecular interactions is not well-known. Examples include most anti-convulsants, diuretics, and vasodilators. Screening in vivo typically returns compounds with acceptable ADME properties and access to the target in vivo; issues that often frustrate the present target based drug discovery programs.


Ketersediaan
EBK-00217615/Bir-fPerpus PusatTersedia
Informasi Detail
Judul Seri
-
No. Panggil
615/Bir-f
Penerbit
United States of America : Frontiers in Pharmacology., 2007
Deskripsi Fisik
68 hlm
Bahasa
Indonesia
ISBN/ISSN
978-2-88919-469-8
Klasifikasi
615
Tipe Isi
text
Tipe Media
e-book
Tipe Pembawa
-
Edisi
-
Subjek
PHENOTYPIC SCREENING
FRONTIERS RESEARCH
Info Detail Spesifik
Electronic Version
Pernyataan Tanggungjawab
-
Versi lain/terkait

Tidak tersedia versi lain

Lampiran Berkas
  • EBK-00217
Komentar

Anda harus masuk sebelum memberikan komentar

Perpustakaan Universitas Mahasaraswati
  • Informasi
  • Layanan
  • Pustakawan
  • Area Anggota

Tentang Kami

Perpustakaan Universitas Mahasaraswati Denpasar tidak terlepas dari awal mula berdirinya Yayasan Perguruan Rakyat Saraswati Denpasar yang didirikan pada tanggal 8 Desember 1946 dengan Motto “GӦNGING MAHȂPȂTAKA MȖDDHA HETU “ yang artinya Kebodohan adalah Sumber Bencana. 

Cari

masukkan satu atau lebih kata kunci dari judul, pengarang, atau subjek


© 2025 — UNMAS Denpasar | IT Division

Ditenagai oleh IT Division
Pilih subjek yang menarik bagi Anda
  • Karya Umum
  • Filsafat
  • Agama
  • Ilmu-ilmu Sosial
  • Bahasa
  • Ilmu-ilmu Murni
  • Ilmu-ilmu Terapan
  • Kesenian, Hiburan, dan Olahraga
  • Kesusastraan
  • Geografi dan Sejarah
Pencarian Spesifik